LINC02209

Across TCGA pan-cancer cohorts, LINC02209 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC02209’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02209 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02209 is over-expressed in tumor.

LUAD, LUSC, and HNSC are the cancer types where LINC02209 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02209 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	II,III,IV	+0.016	.017	4	view →
LUSC	All	All	+0.002	.044	2	view →
HNSC	All	All	+0.010	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC02209–LUAD

Open the LUAD breakdown →